# A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine

> **NCT00169481** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 689 (actual)

## Conditions studied

- Streptococcal Infections

## Interventions

- **BIOLOGICAL:** Pneumococcal (vaccine)

## Key facts

- **NCT ID:** NCT00169481
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 689 (ACTUAL)
- **Last updated:** 2017-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00169481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00169481, "A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00169481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*